317 related articles for article (PubMed ID: 28028556)
1. Effect of intravenous gadoxetate disodium and flip angle on hepatic proton density fat fraction estimation with six-echo, gradient-recalled-echo, magnitude-based MR imaging at 3T.
Park CC; Hamilton G; Desai A; Zand KA; Wolfson T; Hooker JC; Costa E; Heba E; Clark L; Gamst A; Loomba R; Middleton MS; Sirlin CB
Abdom Radiol (NY); 2017 Apr; 42(4):1189-1198. PubMed ID: 28028556
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of multiecho magnitude-based MRI (M-MRI) for estimation of hepatic proton density fat fraction (PDFF) in children.
Zand KA; Shah A; Heba E; Wolfson T; Hamilton G; Lam J; Chen J; Hooker JC; Gamst AC; Middleton MS; Schwimmer JB; Sirlin CB
J Magn Reson Imaging; 2015 Nov; 42(5):1223-32. PubMed ID: 25847512
[TBL] [Abstract][Full Text] [Related]
3. Assessment of a high-SNR chemical-shift-encoded MRI with complex reconstruction for proton density fat fraction (PDFF) estimation overall and in the low-fat range.
Park CC; Hooker C; Hooker JC; Bass E; Haufe W; Schlein A; Covarrubias Y; Heba E; Bydder M; Wolfson T; Gamst A; Loomba R; Schwimmer J; Hernando D; Reeder SB; Middleton M; Sirlin CB; Hamilton G
J Magn Reson Imaging; 2019 Jan; 49(1):229-238. PubMed ID: 29707848
[TBL] [Abstract][Full Text] [Related]
4. Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adults.
Tyagi A; Yeganeh O; Levin Y; Hooker JC; Hamilton GC; Wolfson T; Gamst A; Zand AK; Heba E; Loomba R; Schwimmer J; Middleton MS; Sirlin CB
Abdom Imaging; 2015 Oct; 40(8):3070-7. PubMed ID: 26350282
[TBL] [Abstract][Full Text] [Related]
5. Accuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference.
Heba ER; Desai A; Zand KA; Hamilton G; Wolfson T; Schlein AN; Gamst A; Loomba R; Sirlin CB; Middleton MS
J Magn Reson Imaging; 2016 Feb; 43(2):398-406. PubMed ID: 26201284
[TBL] [Abstract][Full Text] [Related]
6. Agreement between region-of-interest- and parametric map-based hepatic proton density fat fraction estimation in adults with chronic liver disease.
Manning PM; Hamilton G; Wang K; Park C; Hooker JC; Wolfson T; Gamst A; Haufe WM; Schlein AN; Middleton MS; Sirlin CB
Abdom Radiol (NY); 2017 Mar; 42(3):833-841. PubMed ID: 27688063
[TBL] [Abstract][Full Text] [Related]
7. Effect of flip angle on the accuracy and repeatability of hepatic proton density fat fraction estimation by complex data-based, T1-independent, T2*-corrected, spectrum-modeled MRI.
Johnson BL; Schroeder ME; Wolfson T; Gamst AC; Hamilton G; Shiehmorteza M; Loomba R; Schwimmer JB; Reeder S; Middleton MS; Sirlin CB
J Magn Reson Imaging; 2014 Feb; 39(2):440-7. PubMed ID: 23596052
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of PDFF estimation by magnitude-based and complex-based MRI in children with MR spectroscopy as a reference.
Haufe WM; Wolfson T; Hooker CA; Hooker JC; Covarrubias Y; Schlein AN; Hamilton G; Middleton MS; Angeles JE; Hernando D; Reeder SB; Schwimmer JB; Sirlin CB
J Magn Reson Imaging; 2017 Dec; 46(6):1641-1647. PubMed ID: 28323377
[TBL] [Abstract][Full Text] [Related]
9. Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms.
Kang GH; Cruite I; Shiehmorteza M; Wolfson T; Gamst AC; Hamilton G; Bydder M; Middleton MS; Sirlin CB
J Magn Reson Imaging; 2011 Oct; 34(4):928-34. PubMed ID: 21769986
[TBL] [Abstract][Full Text] [Related]
10. MRI proton density fat fraction is robust across the biologically plausible range of triglyceride spectra in adults with nonalcoholic steatohepatitis.
Hong CW; Mamidipalli A; Hooker JC; Hamilton G; Wolfson T; Chen DH; Fazeli Dehkordy S; Middleton MS; Reeder SB; Loomba R; Sirlin CB
J Magn Reson Imaging; 2018 Apr; 47(4):995-1002. PubMed ID: 28851124
[TBL] [Abstract][Full Text] [Related]
11. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
[TBL] [Abstract][Full Text] [Related]
12. Reproducibility of MR-based liver fat quantification across field strength: Same-day comparison between 1.5T and 3T in obese subjects.
Artz NS; Haufe WM; Hooker CA; Hamilton G; Wolfson T; Campos GM; Gamst AC; Schwimmer JB; Sirlin CB; Reeder SB
J Magn Reson Imaging; 2015 Sep; 42(3):811-7. PubMed ID: 25620624
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of and agreement between MR imaging and spectroscopic estimation of hepatic proton density fat fraction in children with known or suspected nonalcoholic fatty liver disease.
Achmad E; Yokoo T; Hamilton G; Heba ER; Hooker JC; Changchien C; Schroeder M; Wolfson T; Gamst A; Schwimmer JB; Lavine JE; Sirlin CB; Middleton MS
Abdom Imaging; 2015 Oct; 40(8):3084-90. PubMed ID: 26205992
[TBL] [Abstract][Full Text] [Related]
14. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
[TBL] [Abstract][Full Text] [Related]
15. Stability of liver proton density fat fraction and changes in R 2* measurements induced by administering gadoxetic acid at 3T MRI.
Sofue K; Zhong X; Nickel MD; Dale BM; Bashir MR
Abdom Radiol (NY); 2016 Aug; 41(8):1555-64. PubMed ID: 27052456
[TBL] [Abstract][Full Text] [Related]
16. Liver MRI in the hepatocyte phase with gadolinium-EOB-DTPA: does increasing the flip angle improve conspicuity and detection rate of hypointense lesions?
Bashir MR; Husarik DB; Ziemlewicz TJ; Gupta RT; Boll DT; Merkle EM
J Magn Reson Imaging; 2012 Mar; 35(3):611-6. PubMed ID: 22034383
[TBL] [Abstract][Full Text] [Related]
17. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.
Idilman IS; Aniktar H; Idilman R; Kabacam G; Savas B; Elhan A; Celik A; Bahar K; Karcaaltincaba M
Radiology; 2013 Jun; 267(3):767-75. PubMed ID: 23382293
[TBL] [Abstract][Full Text] [Related]
18. Hepatic steatosis: effect on hepatocyte enhancement with gadoxetate disodium-enhanced liver MR imaging.
Onishi H; Theisen D; Dietrich O; Reiser MF; Zech CJ
J Magn Reson Imaging; 2014 Jan; 39(1):42-50. PubMed ID: 24339365
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents.
Zhao YZ; Gan YG; Zhou JL; Liu JQ; Cao WG; Cheng SM; Bai DM; Wang MZ; Gao FQ; Zhou SM
World J Gastroenterol; 2019 Mar; 25(12):1513-1523. PubMed ID: 30948914
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of 5-minute delayed transition phase imaging with 30° flip angle in gadoxetic acid-enhanced 3D gradient-echo MRI of liver, compared with 20-minute delayed hepatocyte phase MRI with standard 10° flip angle.
Cho ES; Yu JS; Park AY; Woo S; Kim JH; Chung JJ
AJR Am J Roentgenol; 2015 Jan; 204(1):69-75. PubMed ID: 25539239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
